Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124302693 | 12430269 | 3 | F | 20160307 | 20160617 | 20160602 | 20160701 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-040059 | BRISTOL MYERS SQUIBB | 30.22 | YR | F | Y | 60.00000 | KG | 20160701 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124302693 | 12430269 | 1 | PS | REYATAZ | ATAZANAVIR SULFATE | 1 | Oral | 300 MG, UNK | 21567 | 300 | MG | CAPSULE, HARD | |||||||
| 124302693 | 12430269 | 2 | SS | REYATAZ | ATAZANAVIR SULFATE | 1 | Oral | 400 MG, UNK | 21567 | 400 | MG | CAPSULE, HARD | |||||||
| 124302693 | 12430269 | 3 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DF, UNK | U | U | 0 | 1 | DF | ||||||
| 124302693 | 12430269 | 4 | SS | NORVIR | RITONAVIR | 1 | Oral | 100 MG, UNK | U | U | 0 | 100 | MG | ||||||
| 124302693 | 12430269 | 5 | SS | SPECIAFOLDINE | FOLIC ACID | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124302693 | 12430269 | 1 | HIV infection |
| 124302693 | 12430269 | 3 | Product used for unknown indication |
| 124302693 | 12430269 | 4 | Product used for unknown indication |
| 124302693 | 12430269 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124302693 | 12430269 | OT |
| 124302693 | 12430269 | HO |
| 124302693 | 12430269 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124302693 | 12430269 | Gestational diabetes | |
| 124302693 | 12430269 | Maternal exposure during pregnancy | |
| 124302693 | 12430269 | Stillbirth | |
| 124302693 | 12430269 | Therapeutic response decreased | |
| 124302693 | 12430269 | Treatment noncompliance | |
| 124302693 | 12430269 | Uterine dilation and evacuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124302693 | 12430269 | 1 | 201503 | 201603 | 0 | |
| 124302693 | 12430269 | 2 | 201603 | 0 | ||
| 124302693 | 12430269 | 3 | 201503 | 0 | ||
| 124302693 | 12430269 | 4 | 201503 | 0 |